Combination of micelles and liposomes as a promising drug delivery system: a review

被引:19
作者
Qian, Jiecheng [1 ]
Guo, Yankun [3 ,4 ]
Xu, Youfa [1 ,2 ]
Wang, Xinyu [1 ]
Chen, Jianming [1 ,2 ]
Wu, Xin [1 ,2 ,5 ]
机构
[1] Fujian Univ Tradit Chinese Med, Dept Pharm, Fuzhou, Peoples R China
[2] Shanghai Wei Er Lab, Shanghai, Peoples R China
[3] Tongji Univ, Shanghai Skin Dis Hosp, Dept Pharm, Sch Med, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Dept Pharm, Org Dept, Shanghai Gen Hosp,Sch Med, Shanghai, Peoples R China
[5] Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery MOE, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Micelle; Liposome; Drug delivery; Nanoformulation; Composite carrier; POLYMERIC MICELLES; RESPONSIVE LIPOSOMES; TARGETED DELIVERY; ULTRASOUND; NANOPARTICLES; STRATEGIES; CISPLATIN; TUMOR; GEMCITABINE; PACLITAXEL;
D O I
10.1007/s13346-023-01368-x
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
Among various nanocarriers, liposomes, and micelles are relatively mature drug delivery systems with the advantages of prolonging drug half-life, reducing toxicity, and improving efficacy. However, both have problems, such as poor stability and insufficient targeting. To further exploit the excellent properties of micelles and liposomes and avoid their shortcomings, researchers have developed new drug delivery systems by combining the two and making use of their respective advantages to achieve the goals of increasing the drug loading capacity, multiple targeting, and multiple drug delivery. The results have demonstrated that this new combination approach is a very promising delivery platform. In this paper, we review the combination strategies, preparation methods, and applications of micelles and liposomes to introduce the research progress, advantages, and challenges of composite carriers.
引用
收藏
页码:2767 / 2789
页数:23
相关论文
共 144 条
[31]   Cisplatin: The first metal based anticancer drug [J].
Ghosh, Sumit .
BIOORGANIC CHEMISTRY, 2019, 88
[32]  
Godinho B.M.D.C., 2020, SAUDE TECNOL, P5, DOI [10.25758/set.2227, DOI 10.25758/SET.2227]
[33]   Tumor targeting via EPR: Strategies to enhance patient responses [J].
Golombek, Susanne K. ;
May, Jan-Niklas ;
Theek, Benjamin ;
Appold, Lia ;
Drude, Natascha ;
Kiessling, Fabian ;
Lammers, Twan .
ADVANCED DRUG DELIVERY REVIEWS, 2018, 130 :17-38
[34]   Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives [J].
Gomez-Aguado, Itziar ;
Rodriguez-Castejon, Julen ;
Vicente-Pascual, Monica ;
Rodriguez-Gascon, Alicia ;
Angeles Solinis, Maria ;
del Pozo-Rodriguez, Ana .
NANOMATERIALS, 2020, 10 (02)
[35]   ENZYME ENTRAPMENT IN LIPOSOMES [J].
GREGORIA.G ;
LEATHWOO.PD ;
RYMAN, BE .
FEBS LETTERS, 1971, 14 (02) :95-&
[36]   Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity [J].
Gubernator, Jerzy .
EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (05) :565-580
[37]   Development of Pharmaceutical Nanomedicines: From the Bench to the Market [J].
Halwani, Abdulrahman A. .
PHARMACEUTICS, 2022, 14 (01)
[38]   New intranasal cross-linked mosapride xyloglucan pluronics micelles (MOS-XPMs) for reflux esophagitis disease: In-vitro optimization and improved therapeutic efficacy [J].
Hammad, Reham Waheed ;
Sanad, Rania Abdel-Basset ;
Abdelmalak, Nevine Shawky ;
Torad, Faisal A. ;
Latif, Randa .
JOURNAL OF ADVANCED RESEARCH, 2020, 23 :83-94
[39]  
Hang Z., 2016, Biochemical Compounds, V4, P1, DOI DOI 10.7243/2052-9341-4-2
[40]   ULTRASOUND ENHANCED ENDOCYTOTIC ACTIVITY OF HUMAN FIBROBLASTS [J].
Hauser, Joerg ;
Ellisman, Mark ;
Steinau, Hans-Ulrich ;
Stefan, Esenwein ;
Dudda, Marcel ;
Hauser, Manfred .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2009, 35 (12) :2084-2092